Steward Partners Investment Advisory, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,700 shares of BCLI stock, worth $648. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,700

Previous 4,200 35.71%

Holding current value

$648

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$0.34 - $0.74 $510 - $1,110	-1,500 Reduced 35.71%	2,700 $0
Q4 2023 Feb 12, 2024	SELL	$0.15 - $0.4 $150 - $400	-1,000 Reduced 19.23%	4,200 $1,000
Q3 2023 Nov 13, 2023	SELL	$0.2 - $2.08 $600 - $6,240	-3,000 Reduced 36.59%	5,200 $1,000
Q3 2022 Nov 10, 2022	BUY	$2.55 - $4.42 $3,824 - $6,630	1,500 Added 22.39%	8,200 $36,000
Q2 2022 Aug 04, 2022	SELL	$2.71 - $3.6 $2,710 - $3,600	-1,000 Reduced 12.99%	6,700 $18,000
Q1 2022 May 02, 2022	SELL	$2.92 - $4.19 $5,840 - $8,380	-2,000 Reduced 20.62%	7,700 $26,000
Q4 2021 Feb 08, 2022	SELL	$2.81 - $4.23 $20,513 - $30,879	-7,300 Reduced 42.94%	9,700 $39,000
Q3 2021 Nov 12, 2021	SELL	$3.14 - $4.09 $6,280 - $8,180	-2,000 Reduced 10.53%	17,000 $56,000
Q2 2021 Aug 13, 2021	SELL	$3.01 - $4.01 $35,518 - $47,318	-11,800 Reduced 38.31%	19,000 $72,000
Q1 2021 May 14, 2021	BUY	$3.46 - $7.88 $53,630 - $122,140	15,500 Added 101.31%	30,800 $117,000
Q4 2020 Feb 11, 2021	SELL	$3.99 - $17.73 $40,299 - $179,073	-10,100 Reduced 39.76%	15,300 $69,000
Q3 2020 Oct 30, 2020	BUY	$11.19 - $16.92 $6,714 - $10,152	600 Added 2.42%	25,400 $430,000
Q2 2020 Aug 06, 2020	BUY	$4.42 - $12.66 $24,310 - $69,630	5,500 Added 28.5%	24,800 $278,000
Q1 2020 Apr 29, 2020	BUY	$4.01 - $8.88 $63,358 - $140,304	15,800 Added 451.43%	19,300 $89,000
Q4 2019 Jan 17, 2020	BUY	$3.62 - $4.29 $3,620 - $4,290	1,000 Added 40.0%	3,500 $14,000
Q2 2019 Jul 25, 2019	BUY	$3.59 - $4.3 $8,975 - $10,750	2,500 New	2,500 $9,000
Q4 2018 Jan 15, 2019	SELL	$2.98 - $3.9 $17,880 - $23,400	-6,000 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$3.73 - $4.38 $22,380 - $26,280	6,000 New	6,000 $23,000
Q2 2018 Jul 20, 2018	SELL	$3.12 - $5.19 $9,360 - $15,570	-3,000 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$2.96 - $4.42 $8,880 - $13,260	3,000	3,000 $11,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

12.3M

Call Options Held

169K

Put Options Held

30.6K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $8.76M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Brainstorm Cell Therapeutics Inc. Transaction History